Published in J Immunother on November 01, 1997
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target. Proc Natl Acad Sci U S A (2004) 5.13
Prognostic significance of CD45RO+ memory T cells in renal cell carcinoma. Br J Cancer (2011) 1.25
Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34
Workshop report: AIDS and stigma: a conceptual framework and research agenda. AIDS Public Policy J (1998) 2.90
T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med (1988) 2.63
Mutant bacteria showing efficient utilization of thymidine. J Bacteriol (1966) 2.41
Characterization of two bacterial mutants with temperature-sensitive synthesis of DNA. Genetics (1968) 2.32
Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. Cancer Res (1993) 2.01
Long-term follow-up after partial removal of a solitary kidney. N Engl J Med (1991) 1.99
T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Res (1993) 1.98
A simplified method of CD34+ cell determination for peripheral blood progenitor cell transplantation and correlation with clinical engraftment. Exp Hematol (1998) 1.96
Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials. Br J Cancer (2004) 1.94
Organic solvents as probes for the structure and function of the bacterial membrane: effects of ethanol on the wild type and an ethanol-resistant mutant of Escherichia coli K-12. J Bacteriol (1973) 1.88
Enzyme immunohistochemistry: technical aspects. Semin Diagn Pathol (1984) 1.83
TNM staging of renal cell carcinoma: Workgroup No. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer (1997) 1.80
The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. J Immunol (1998) 1.72
Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura. Blood (1977) 1.62
The axes of rotation of the thumb carpometacarpal joint. J Orthop Res (1992) 1.60
Human neoplasm pH and response to radiation therapy: P-31 MR spectroscopy studies in situ. Radiology (1989) 1.59
Clinicopathologic reassessment of primary cutaneous B-cell lymphomas with immunophenotypic and molecular genetic characterization. Am J Surg Pathol (2000) 1.59
Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease. Gastroenterology (1984) 1.49
Erdheim-Chester disease. Case report and review of the literature. Am J Med (1986) 1.44
Rheumatoid arthritis complicated by infection with the human immunodeficiency virus and the development of Sjögren's syndrome. Arthritis Rheum (1989) 1.44
New approaches to HIV surveillance: means and ends. Summary report of conference held at Yale University, 21-22 May 1998, by the Law, Policy and Ethics Core, Center for Interdisciplinary Research on AIDS, Yale University. AIDS Public Policy J (1999) 1.43
Wegener's granulomatosis. Immunomicroscopic and ultrastructural study of four cases. Arch Pathol Lab Med (1990) 1.39
Combination chemotherapy for islet cell carcinoma and metastatic carcinoid tumors with 5-fluorouracil and streptozotocin. Cancer Treat Rep (1979) 1.36
The treatment of thrombotic thrombocytopenic purpura with exchange transfusions, plasma infusions, and plasma exchange. Semin Hematol (1987) 1.34
Splenic T-killer cells can be generated by allogeneic thymic cells in conjunction with assisting factor. Nature (1977) 1.32
The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis. Am J Surg Pathol (2000) 1.30
Exchange transfusions in the treatment of thrombotic thrombocytopenic purpura. Semin Hematol (1976) 1.28
Interleukin 2 deficiency in murine Leishmaniasis donovani and its relationship to depressed spleen cell responses to phytohemagglutinin. J Immunol (1983) 1.25
Adult murine lymph node cells respond blastogenically to a new differentiation antigen on isologous and autologous B lymphocytes. J Immunol (1975) 1.22
A phase I study of sunitinib plus bevacizumab in advanced solid tumors. Clin Cancer Res (2009) 1.19
Infectious crystalline keratopathy. Am J Ophthalmol (1984) 1.18
Estrogen receptor mutations in tamoxifen-resistant breast cancer. Cancer Res (1994) 1.17
Multicenter, randomized, phase III trial of CD8(+) tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinoma. J Clin Oncol (1999) 1.15
Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis. Clin Cancer Res (2001) 1.14
Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12. J Immunol (1996) 1.13
Generation of alloreactive cytotoxic T lymphocytes: evidence for a differentiation factor distinct from IL 2. J Immunol (1983) 1.12
Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma. Br J Cancer (2005) 1.12
Bioluminescence imaging of lymphocyte trafficking in vivo. Exp Hematol (2001) 1.11
Membranous glomerulonephritis associated with industrial mercury exposure. Study of pathogenetic mechanisms. Am J Clin Pathol (1982) 1.11
Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders. Am J Clin Pathol (1998) 1.11
Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy. J Natl Cancer Inst (1993) 1.11
Mechanisms of apoptosis in T cells from patients with renal cell carcinoma. Clin Cancer Res (1999) 1.09
Interferon gamma and interleukin 2 synergize to induce selective monokine expression in murine peritoneal macrophages. J Biol Chem (1990) 1.09
In situ hybridization analysis of lymphoproliferative disorders. Assessment of clonality by immunoglobulin light-chain messenger RNA expression. Diagn Mol Pathol (1994) 1.08
The axes of rotation of the thumb interphalangeal and metacarpophalangeal joints. Clin Orthop Relat Res (1995) 1.08
Human intestinal mucosal mononuclear cells exhibit lymphokine-activated killer cell activity. Gastroenterology (1985) 1.08
Intracranial extension of inflammatory pseudotumor of the orbit. Case report. J Neurosurg (1984) 1.08
Thrombotic thrombocytopenic purpura: a review. Prog Hemost Thromb (1982) 1.08
Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma. A multivariate analysis. Cancer (1992) 1.07
Renal oncocytoma: clinical and biological correlates. J Urol (1993) 1.07
Pulmonary vasculitis (Wegener's granulomatosis). Immunohistochemical study of T and B cell markers. Am J Med (1983) 1.06
Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma. Mod Pathol (2001) 1.06
Prostacyclin therapy of thrombotic thrombocytopenic purpura. Lancet (1980) 1.05
Studies of a thermolabile repressor. Biochim Biophys Acta (1965) 1.05
Immunohistologic cellular phenotypes of lymphoproliferative disorders. Comprehensive evaluation of 564 cases including 257 non-Hodgkin's lymphomas classified by the International Working Formulation. Am J Pathol (1983) 1.05
Light chain nephropathy. Am J Med (1981) 1.05
Plasmacytoma of the ovary: a case report and literature review. Gynecol Oncol (1999) 1.02
The pulmonary manifestations of systemic lupus erythematosus. Semin Arthritis Rheum (1985) 1.02
Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cells. J Clin Invest (1999) 1.02
Successful combination chemotherapy for metastatic parathyroid carcinoma. Arch Intern Med (1984) 1.01
Recurrent subarachnoid hemorrhage associated with aminocaproic acid therapy and acute renal artery thrombosis. Case report. J Neurosurg (1979) 1.01
The use of amplified variable number of tandem repeats (VNTR) in the detection of chimerism following bone marrow transplantation. A comparison with restriction fragment length polymorphism (RFLP) by Southern blotting. Am J Clin Pathol (1997) 1.00
Giant cell myocarditis. Arch Pathol Lab Med (1980) 1.00
Identification of monoclonal B-cell populations by rapid cycle polymerase chain reaction. A practical screening method for the detection of immunoglobulin gene rearrangements. Am J Pathol (1992) 0.99
An approach to immunomicroscopy of renal disease with immunoperoxidase and periodic acid-Schiff counterstain (IMPAS stain). Am J Clin Pathol (1980) 0.99
Squamous cell carcinoma of the nail bed: a clinicopathological study of 12 cases. Br J Dermatol (1990) 0.99
Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer. Clin Cancer Res (1998) 0.99
T cells from renal cell carcinoma patients exhibit an abnormal pattern of kappa B-specific DNA-binding activity: a preliminary report. Cancer Res (1994) 0.98
p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer. Cancer (1997) 0.98
Inhibition of NF-kappa B activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3. J Immunol (1999) 0.98
HIV infection among Brazilian transvestites in a prison population. AIDS Patient Care STDS (1996) 0.97
Placental mononuclear phagocytes as a source of interleukin-1. Science (1982) 0.97
The effect of fixation on detection of B-cell clonality by polymerase chain reaction. Mod Pathol (1999) 0.96
Fixation conditions for DNA and RNA in situ hybridization: a reassessment of molecular morphology dogma. Am J Pathol (1998) 0.95
Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes. Int J Cancer (1995) 0.95
Alterations in NFkappaB activation in T lymphocytes of patients with renal cell carcinoma. J Natl Cancer Inst (1999) 0.94
Colonic vasoactive intestinal peptide nerves in inflammatory bowel disease. Gastroenterology (1992) 0.94
Autoimmune and iatrogenic causes of lymphadenopathy. Semin Oncol (1993) 0.93
Tissue immunomicroscopic evaluation of monoclonality of B-cell lymphomas: comparison with cell suspension studies. Am J Clin Pathol (1981) 0.93
Characterization of a human renal cell carcinoma specific cytotoxic CD8+ T cell line. J Immunother (1991) (1992) 0.93
Dead or dying: necrosis versus apoptosis in caspase-deficient human renal cell carcinoma. Cancer Res (1999) 0.93
Efficacy of multimodality therapy in advanced renal cell carcinoma. Urology (1998) 0.93
Use of novel t(11;14) and t(14;18) dual-fusion fluorescence in situ hybridization probes in the differential diagnosis of lymphomas of small lymphocytes. Diagn Mol Pathol (2001) 0.92
Characterization of two cell lines with distinct phenotypes and genotypes established from a patient with renal cell carcinoma. Cancer Res (1989) 0.92
Validation of a multicolor interphase fluorescence in situ hybridization assay for detection of transitional cell carcinoma on fresh and archival thin-layer, liquid-based cytology slides. Anal Quant Cytol Histol (2001) 0.92
Caspase-dependent and -independent death pathways in cancer therapy. Apoptosis (2000) 0.92